Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

First heterozygous NOP10 mutation in Familial Pulmonary Fibrosis.

Kannengiesser C, Manali ED, Revy P, Callebaut I, Ba I, Borgel A, Oudin C, Haritou A, Kolilekas L, Malagari K, Borie R, Lainey E, Boileau C, Crestani B, Papiris SA.

Eur Respir J. 2020 Mar 5. pii: 1902465. doi: 10.1183/13993003.02465-2019. [Epub ahead of print] No abstract available.

PMID:
32139460
2.

Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.

Papiris SA, Griese M, Manali ED.

N Engl J Med. 2020 Jan 9;382(2):197. doi: 10.1056/NEJMc1914606. No abstract available.

PMID:
31914249
3.

Primary Hemangiopericytoma Arising in Extralobar Pulmonary Sequestration: A Coincidence or Two Rare Disorders?

Kampolis CF, Damaskos C, Loukeri AA, Garmpis N, Garmpi A, Tomos I, Spartalis E, Dimitroulis D, Patsouras A, Douskou M, Papiris SA, Tomos P.

In Vivo. 2019 Nov-Dec;33(6):2141-2145. doi: 10.21873/invivo.11715.

4.

Emerging phenotypes of sarcoidosis based on 18F-FDG PET/CT: a hierarchical cluster analysis.

Papiris SA, Georgakopoulos A, Papaioannou AI, Pianou N, Kallergi M, Kelekis NL, Gialafos H, Manali ED, Chatziioannou S.

Expert Rev Respir Med. 2020 Feb;14(2):229-238. doi: 10.1080/17476348.2020.1684902. Epub 2019 Oct 29.

PMID:
31647341
5.

18F-FDG PET/CT in Pulmonary Sarcoidosis:Quantifying Inflammation by the TLG index.

Papiris SA, Manali ED, Pianou NK, Kallergi M, Papaioannou AI, Georgakopoulos A, Malagari K, Kelekis NL, Gialafos H, Chatziioannou S.

Expert Rev Respir Med. 2020 Jan;14(1):103-110. doi: 10.1080/17476348.2020.1682997. Epub 2019 Oct 24.

PMID:
31626563
6.

The significance of clinical awareness of anatomical variations.

Tomos I, Raptakis T, Economopoulos N, Papiris SA, Karakatsani A.

Adv Respir Med. 2019;87(4):255-256. doi: 10.5603/ARM.a2019.0045. No abstract available.

7.

Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison.

Papiris SA, Tsirigotis P, Kannengiesser C, Kolilekas L, Gkirkas K, Papaioannou AI, Revy P, Giouleka P, Papadaki G, Kagouridis K, Pappa V, Borie R, Boileau C, Bouros D, Crestani B, Manali ED.

Respir Res. 2019 Aug 13;20(1):182. doi: 10.1186/s12931-019-1151-6.

8.

Bi-allelic missense ABCA3 mutations in a patient with childhood ILD who reached adulthood.

Manali ED, Legendre M, Nathan N, Kannengiesser C, Coulomb-L'Hermine A, Tsiligiannis T, Tomos P, Griese M, Borie R, Clement A, Amselem S, Crestani B, Papiris SA.

ERJ Open Res. 2019 Jul 22;5(3). pii: 00066-2019. doi: 10.1183/23120541.00066-2019. eCollection 2019 Jul.

9.

A Woman with Hemoptysis and Unilateral Reticular Interstitial Opacities.

Tomos I, Economopoulos N, Papiris SA, Karakatsani A.

Ann Am Thorac Soc. 2019 Mar;16(3):371-375. doi: 10.1513/AnnalsATS.201806-395CC. No abstract available.

PMID:
30821492
10.

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, González-Pérez MI, Mejía M, Buendía-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Lioté H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clément A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieudé P.

N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.

11.

Ability of using different dry powder inhalers during COPD exacerbations.

Papaioannou AI, Herodotou Y, Tomos I, Apollonatou V, Verykokou G, Papathanasiou E, Manali ED, Loukides S, Papiris SA.

Pulm Pharmacol Ther. 2018 Feb;48:211-216. doi: 10.1016/j.pupt.2017.12.007. Epub 2017 Dec 19.

PMID:
29277688
12.

High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.

Papiris SA, Tomos IP, Karakatsani A, Spathis A, Korbila I, Analitis A, Kolilekas L, Kagouridis K, Loukides S, Karakitsos P, Manali ED.

Cytokine. 2018 Feb;102:168-172. doi: 10.1016/j.cyto.2017.08.019. Epub 2017 Aug 25.

PMID:
28847533
13.

Desert dust outbreaks and respiratory morbidity in Athens, Greece.

Trianti SM, Samoli E, Rodopoulou S, Katsouyanni K, Papiris SA, Karakatsani A.

Environ Health. 2017 Jul 1;16(1):72. doi: 10.1186/s12940-017-0281-x.

14.

Exhaled Breath Condensate Acidification Occurs During Surgery for Abdominal Cancer.

Mahairidou A, Rodopoulou S, Tomos I, Maratou E, Manali E, Raptakis T, Papiris SA, Karakatsani A.

Anticancer Res. 2017 Jun;37(6):3315-3321.

PMID:
28551684
15.

Lung cancer in patients with idiopathic pulmonary fibrosis.

Karampitsakos T, Tzilas V, Tringidou R, Steiropoulos P, Aidinis V, Papiris SA, Bouros D, Tzouvelekis A.

Pulm Pharmacol Ther. 2017 Aug;45:1-10. doi: 10.1016/j.pupt.2017.03.016. Epub 2017 Apr 1. Review.

PMID:
28377145
16.

Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the 'bed' that counts and not 'the sleepers'.

Tomos IP, Tzouvelekis A, Aidinis V, Manali ED, Bouros E, Bouros D, Papiris SA.

Expert Rev Respir Med. 2017 Apr;11(4):299-309. doi: 10.1080/17476348.2017.1300533. Epub 2017 Mar 8. Review.

PMID:
28274188
17.

The New Idiopathic Pulmonary Fibrosis Acute Exacerbations Document: One Step Ahead but Still Suspended in the Air.

Papiris SA, Kagouridis K, Kolilekas L, Karakatsani A, Korbila I, Giouleka P, Papadaki G, Maniati M, Bouros D, Manali ED.

Am J Respir Crit Care Med. 2017 Jan 15;195(2):267-269. doi: 10.1164/rccm.201607-1426LE. No abstract available.

PMID:
28084826
18.

Unilateral hypertransparency on chest radiograph: the congenital Poland Syndrome.

Tomos I, Papaioannou AI, Vlami A, Apollonatou V, Manali ED, Papiris SA.

Adv Respir Med. 2016;84(6):342-343. doi: 10.5603/ARM.2016.0045.

19.

Activin A and follistatin in patients with asthma. Does severity make the difference?

Papaporfyriou A, Bakakos P, Kostikas K, Papatheodorou G, Hillas G, Trigidou R, Katafigiotis P, Koulouris NG, Papiris SA, Loukides S.

Respirology. 2017 Apr;22(3):473-479. doi: 10.1111/resp.12937. Epub 2016 Nov 2.

PMID:
27807906
20.

Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract.

Papaioannou AI, Kostikas K, Manali ED, Papadaki G, Roussou A, Kolilekas L, Borie R, Bouros D, Papiris SA.

Respir Med. 2016 Aug;117:14-26. doi: 10.1016/j.rmed.2016.05.005. Epub 2016 May 7. Review.

21.

Celebrating Two Centuries since the Invention of the Stethoscope. René Théophile Hyacinthe Laënnec (1781-1826).

Tomos I, Karakatsani A, Manali ED, Papiris SA.

Ann Am Thorac Soc. 2016 Oct;13(10):1667-1670.

PMID:
27467020
22.

Diffuse Idiopathic Skeletal Hyperostosis (DISH) and non small cell lung cancer: case presentation and review of the literature.

Tomos I, Vlami A, Karakatsani A, Korbila I, Manali ED, Papiris SA.

Pneumonol Alergol Pol. 2016;84(2):116-8. doi: 10.5603/PiAP.2016.0010. Review.

23.

Acute Respiratory Events in Connective Tissue Disorders.

Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Maniati M, Filippatos G, Bouros D.

Respiration. 2016;91(3):181-201. doi: 10.1159/000444535. Epub 2016 Mar 4. Review.

24.

Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach.

Papiris SA, Kagouridis K, Kolilekas L, Papaioannou AI, Roussou A, Triantafillidou C, Baou K, Malagari K, Argentos S, Kotanidou A, Karakatsani A, Manali ED.

BMC Pulm Med. 2015 Dec 14;15:162. doi: 10.1186/s12890-015-0146-4.

25.

The Ring of the Aortas: The Silent Variation.

Tomos I, Vlami A, Korbila I, Manali ED, Karakatsani A, Papiris SA.

Ann Thorac Surg. 2015 Dec;100(6):2371. doi: 10.1016/j.athoracsur.2015.08.065. No abstract available.

PMID:
26652542
26.

Cardiovascular risk in pulmonary alveolar proteinosis.

Manali ED, Papadaki G, Konstantonis D, Tsangaris I, Papaioannou AI, Kolilekas L, Schams A, Kagouridis K, Karakatsani A, Orfanos S, Griese M, Papiris SA.

Expert Rev Respir Med. 2016 Feb;10(2):235-40. doi: 10.1586/17476348.2016.1116389. Epub 2015 Nov 27.

PMID:
26558331
27.

"Luck's always to blame": silent wounds of a penetrating gunshot trauma sustained 20 years ago.

Tomos I, Manali ED, Argentos S, Raptakis T, Papiris SA.

Pneumonol Alergol Pol. 2015;83(5):392-3. doi: 10.5603/PiAP.2015.0063.

28.

Investigation of Lung Involvement in Connective Tissue Disorders.

Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Maniati M, Borie R, Pradere P, Crestani B, Bouros D.

Respiration. 2015;90(1):2-24. doi: 10.1159/000435817. Epub 2015 Jun 26. Review.

29.

Pulmonary alveolar proteinosis: time to shift?

Papiris SA, Tsirigotis P, Kolilekas L, Papadaki G, Papaioannou AI, Triantafillidou C, Papaporfyriou A, Karakatsani A, Kagouridis K, Griese M, Manali ED.

Expert Rev Respir Med. 2015 Jun;9(3):337-49. doi: 10.1586/17476348.2015.1035259. Epub 2015 Apr 12. Review.

PMID:
25864717
30.

Patterns of airway involvement in inflammatory bowel diseases.

Papanikolaou I, Kagouridis K, Papiris SA.

World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):560-9. doi: 10.4291/wjgp.v5.i4.560. Review.

31.

Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose.

Papiris SA, Tsirigotis P, Kolilekas L, Papadaki G, Papaioannou AI, Triantafillidou C, Papaporfyriou A, Karakatsani A, Kagouridis K, Griese M, Manali ED.

Clin Drug Investig. 2014 Aug;34(8):553-64. doi: 10.1007/s40261-014-0208-z.

PMID:
24890235
32.

Idiopathic pulmonary fibrosis acute exacerbations: where are we now?

Papiris SA, Kagouridis K, Kolilekas L, Bouros D, Manali ED.

Expert Rev Respir Med. 2014 Jun;8(3):271-3. doi: 10.1586/17476348.2014.896206. Epub 2014 Mar 22.

PMID:
24655104
33.

The Role of Cardiopulmonary Exercise Test in IPF Prognosis.

Triantafillidou C, Manali E, Lyberopoulos P, Kolilekas L, Kagouridis K, Gyftopoulos S, Vougas K, Kotanidou A, Alchanatis M, Karakatsani A, Papiris SA.

Pulm Med. 2013;2013:514817. doi: 10.1155/2013/514817. Epub 2013 Oct 31.

34.

Treating CTDs related fibrotic ILDs by immunosuppressants: "facts and faults".

Papiris SA, Kagouridis K, Papadaki G, Kolilekas L, Manali ED.

Lung. 2014 Apr;192(2):221-3. doi: 10.1007/s00408-013-9532-y. Epub 2013 Nov 12.

PMID:
24217988
35.

Bronchiolitis: adopting a unifying definition and a comprehensive etiological classification.

Papiris SA, Malagari K, Manali ED, Kolilekas L, Triantafillidou C, Baou K, Rontogianni D, Bouros D, Kagouridis K.

Expert Rev Respir Med. 2013 Jun;7(3):289-306. doi: 10.1586/ers.13.21. Review.

PMID:
23734650
36.

Combined pulmonary fibrosis and emphysema.

Papiris SA, Triantafillidou C, Manali ED, Kolilekas L, Baou K, Kagouridis K, Bouros D.

Expert Rev Respir Med. 2013 Feb;7(1):19-31; quiz 32. doi: 10.1586/ers.12.80. Review.

PMID:
23362797
37.

Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation?

Papiris SA, Kagouridis K, Kolilekas L, Triantafillidou C, Tsangaris I, Manali ED.

Eur Respir J. 2012 Sep;40(3):794-5. doi: 10.1183/09031936.00114311. No abstract available.

38.

Serologic evaluation in idiopathic interstitial pneumonias.

Papiris SA, Kagouridis K, Bouros D.

Curr Opin Pulm Med. 2012 Sep;18(5):433-40. doi: 10.1097/MCP.0b013e3283560840. Review.

PMID:
22699420
39.

Steroids in idiopathic pulmonary fibrosis acute exacerbation: defenders or killers?

Papiris SA, Manali ED, Kolilekas L, Triantafillidou C, Tsangaris I, Kagouridis K.

Am J Respir Crit Care Med. 2012 Mar 1;185(5):587-8. No abstract available.

PMID:
22383571
40.

Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.

Psallidas I, Stathopoulos GT, Maniatis NA, Magkouta S, Moschos C, Karabela SP, Kollintza A, Simoes DC, Kardara M, Vassiliou S, Papiris SA, Roussos C, Kalomenidis I.

Oncogene. 2013 Jan 24;32(4):528-35. doi: 10.1038/onc.2012.57. Epub 2012 Feb 27.

PMID:
22370646
41.

Medical Research Council dyspnea scale does not relate to fibroblast foci profusion in IPF.

Triantafillidou C, Manali ED, Magkou C, Sotiropoulou C, Kolilekas LF, Kagouridis K, Rontogianni D, Papiris SA.

Diagn Pathol. 2011 Apr 5;6:28. doi: 10.1186/1746-1596-6-28.

42.

Clinical review: idiopathic pulmonary fibrosis acute exacerbations--unravelling Ariadne's thread.

Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Triantafillidou C, Tsangaris I, Roussos C.

Crit Care. 2010;14(6):246. doi: 10.1186/cc9241. Epub 2010 Dec 22. Review.

43.

Diagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study.

Porfyridis I, Plachouras D, Karagianni V, Kotanidou A, Papiris SA, Giamarellou H, Giamarellos-Bourboulis EJ.

BMC Infect Dis. 2010 Sep 29;10:286. doi: 10.1186/1471-2334-10-286.

44.

Amiodarone: review of pulmonary effects and toxicity.

Papiris SA, Triantafillidou C, Kolilekas L, Markoulaki D, Manali ED.

Drug Saf. 2010 Jul 1;33(7):539-58. doi: 10.2165/11532320-000000000-00000. Review.

PMID:
20553056
45.

MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study.

Manali ED, Lyberopoulos P, Triantafillidou C, Kolilekas LF, Sotiropoulou C, Milic-Emili J, Roussos C, Papiris SA.

BMC Pulm Med. 2010 May 28;10:32. doi: 10.1186/1471-2466-10-32.

46.

High dose-rate endobronchial radiotherapy for proximal airway obstruction due to lung cancer: 8-year experience of a referral center.

Manali ED, Stathopoulos GT, Gildea TR, Fleming P, Thornton J, Xu M, Papiris SA, Mehta AC, Mughal MM.

Cancer Biother Radiopharm. 2010 Apr;25(2):207-13. doi: 10.1089/cbr.2009.0689.

PMID:
20423234
47.

Acute severe asthma: new approaches to assessment and treatment.

Papiris SA, Manali ED, Kolilekas L, Triantafillidou C, Tsangaris I.

Drugs. 2009;69(17):2363-91. doi: 10.2165/11319930-000000000-00000.

PMID:
19911854
48.

Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.

Tsimogianni AM, Papiris SA, Kanavaki S, Stathopoulos GT, Sotiropoulou C, Manali ED, Michalopoulou P, Roussos C, Kotanidou A.

Respirology. 2009 Nov;14(8):1114-20. doi: 10.1111/j.1440-1843.2009.01615.x. Epub 2009 Sep 16.

PMID:
19761538
49.

Predictors of outcome after exacerbation of chronic obstructive pulmonary disease.

Tsimogianni AM, Papiris SA, Stathopoulos GT, Manali ED, Roussos C, Kotanidou A.

J Gen Intern Med. 2009 Sep;24(9):1043-8. doi: 10.1007/s11606-009-1061-2. Epub 2009 Jul 14.

50.

Osteopontin is upregulated in malignant and inflammatory pleural effusions.

Moschos C, Porfiridis I, Psallidas I, Kollintza A, Stathopoulos GT, Papiris SA, Roussos C, Kalomenidis I.

Respirology. 2009 Jul;14(5):716-22. doi: 10.1111/j.1440-1843.2009.01536.x. Epub 2009 May 19.

PMID:
19476604

Supplemental Content

Loading ...
Support Center